Immunological drivers of oxidative stress in glaucoma: implications for antioxidant therapy
Graefe's Archive for Clinical and Experimental Ophthalmology · 2026-11 · 264 (11) · 3373-3385
DOI: 10.1007/s00417-026-07445-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Graefe's Archive for Clinical and Experimental Ophthalmology, online erschienen am 08.08.2026. Verfasst von Bin Lin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Xiamen Eye Center and Eye Institute of Xiamen University, School of Medicine, Xiamen, 361000, China. Hauptthemen laut MEDLINE: Oxidative Stress, Antioxidants, Glaucoma, Retinal Ganglion Cells. Die Arbeit nennt 88 Literaturangaben. Gefördert von: Quanzhou City Science and Technology Program.
Abstract (Originalsprache)
Glaucoma is a progressive neurodegenerative disorder characterized by RGC loss and irreversible visual impairment, representing the second leading cause of global blindness. Immune-inflammatory responses and oxidative stress are core pathological drivers of glaucomatous optic nerve degeneration, forming a vicious cycle via the TLR4/NF-κB/NLRP3 inflammasome axis, complement overactivation, and dysregulation of the endogenous antioxidant system. These processes trigger sustained neuroinflammation, mitochondrial dysfunction, and RGC apoptosis. Antioxidant therapies targeting the immune-oxidative stress axis have emerged as promising neuroprotective strategies, including classic antioxidants, Nrf2 activators (e.g., NOB), nanocarrier-mediated targeted delivery systems, and PBM. This mini-review summarizes key molecular mechanisms linking immune activation and oxidative damage in glaucoma, reviews recent advances in the development of antioxidant therapeutics, and discusses current challenges and future directions for clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xiamen Eye Center and Eye Institute of Xiamen University, School of Medicine, Xiamen, 361000, China.
- Xiamen Clinical Research Center for Eye Diseases, Xiamen, 361000, Fujian, China.
- Xiamen Key Laboratory of Ophthalmology, Xiamen, 361000, Fujian, China.
- Fujian Key Laboratory of Corneal & Ocular Surface Diseases, Xiamen, 361000, Fujian, China.
- Xiamen Key Laboratory of Corneal & Ocular Surface Diseases, Xiamen, 361000, Fujian, China.
- Translational Medicine Institute of Xiamen Eye Center of Xiamen University, No.336 Xiahe Road, Xiamen, 361000, Fujian, China.
Förderung
- Quanzhou City Science and Technology Program
Zitieren
APA
Lin, B., Fan, W., & Li, D. K. (2026). Immunological drivers of oxidative stress in glaucoma: implications for antioxidant therapy. Graefe's Archive for Clinical and Experimental Ophthalmology, 264(11), 3373-3385. https://doi.org/10.1007/s00417-026-07445-4
Vancouver
Lin B, Fan W, Li DK. Immunological drivers of oxidative stress in glaucoma: implications for antioxidant therapy. Graefe's Archive for Clinical and Experimental Ophthalmology. 2026;264(11):3373-3385. doi:10.1007/s00417-026-07445-4
BibTeX
@article{Lin2026,
author = {Lin, Bin and Fan, Wei and Li, Dong-Kan},
title = {Immunological drivers of oxidative stress in glaucoma: implications for antioxidant therapy},
journal = {Graefe's Archive for Clinical and Experimental Ophthalmology},
year = {2026},
volume = {264},
number = {11},
pages = {3373--3385},
doi = {10.1007/s00417-026-07445-4}
}
EUVIMED